C-reactive protein induces NF-kappaB activation through intracellular calcium and ROS in human mesangial cells

Nephron Exp Nephrol. 2005;101(4):e165-72. doi: 10.1159/000087940. Epub 2005 Aug 30.

Abstract

Background: C-reactive protein (CRP) is known to have a direct proinflammatory effect in endothelial cells. However, little is known about the effect of CRP in intrinsic renal cells. We investigated the effects of CRP on the nuclear factor-kappaB (NF-kappaB) activation and monocyte chemoattractant protein-1 (MCP-1) gene expression in human mesangial cells and also examined whether intracellular calcium and reactive oxygen species (ROS) were involved in the CRP- induced NF-kappaB activation.

Methods: NF-kappaB binding activity and MCP-1 mRNA expression were measured by electrophoretic mobility shift assay and Northern blot analysis, respectively. Intracellular calcium was monitored by confocal microscopy using calcium sensitive dye, Fluo-3 and intracellular ROS production was determined, using 2',7'-dichlorofluorescin diacetate.

Results: CRP increased NF-kappaB binding activity in a dose-dependent manner (12.5-100 microg/ml), which was induced within 1 h after incubation and peaked around 3 h. CRP also increased the MCP-1 mRNA expression via activation of NF-kappaB. Both intracellular calcium and ROS was induced by CRP. Calcium chelator, BAPTA-AM and anti-oxidants such as N-acetylcysteine and tiron suppressed CRP-induced NF-kappaB activation.

Conclusion: CRP exerted a proinflammatory effect in human mesangial cells by inducing MCP-1 gene expression via NF-kappaB activation, which was mediated, at least in part, through intracellular calcium and ROS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / pharmacology
  • Acetylcysteine / pharmacology
  • Antioxidants / pharmacology
  • Blotting, Northern
  • C-Reactive Protein / pharmacology*
  • C-Reactive Protein / physiology*
  • Calcium / metabolism*
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism
  • Dose-Response Relationship, Drug
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Electrophoretic Mobility Shift Assay
  • Gene Expression Regulation
  • Humans
  • Inflammation
  • Mesangial Cells / chemistry
  • Mesangial Cells / drug effects
  • Mesangial Cells / metabolism*
  • Microscopy, Confocal
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • RNA, Messenger / analysis
  • RNA, Messenger / genetics
  • Reactive Oxygen Species / metabolism*
  • Recombinant Proteins / pharmacology
  • Time Factors

Substances

  • Antioxidants
  • Chelating Agents
  • Chemokine CCL2
  • NF-kappa B
  • RNA, Messenger
  • Reactive Oxygen Species
  • Recombinant Proteins
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
  • Egtazic Acid
  • C-Reactive Protein
  • Calcium
  • Acetylcysteine